Posts in

Archives


NEW YORK, Jan. 27, 2021 (GLOBE NEWSWIRE) – Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapies to treat progressive non-viral liver disease, today announced that an analyst’s note commenting on the listing of Intercept’s product on the United States Food and Drug Administration (FDA) Adverse Event …

A new report from the Anti-Fraud Collaboration has found common themes among the SEC’s enforcement actions on financial statement fraud, including types of fraud schemes, industries, perpetrators and size of l ‘company. The report provides information to deter and detect fraud at a time when the COVID-19 pandemic is increasing the risk of financial reporting …